Repligen (RGEN) Short Interest Ratio & Short Volume $140.79 +8.43 (+6.37%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Repligen Short Interest DataCurrent Short Interest4,230,000 sharesPrevious Short Interest4,210,000 sharesChange Vs. Previous Month+0.48%Dollar Volume Sold Short$518.60 millionShort Interest Ratio6.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares55,880,000 sharesFloat Size51,960,000 sharesShort Percent of Float8.14%Today's Trading Volume1,122,092 sharesAverage Trading Volume613,169 sharesToday's Volume Vs. Average183% Short Selling Repligen ? Sign up to receive the latest short interest report for Repligen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGEN Short Interest Over TimeRGEN Days to Cover Over TimeRGEN Percentage of Float Shorted Over Time Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. Repligen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20244,230,000 shares $518.60 million +0.5%8.1%6.1 $122.60 6/30/20244,210,000 shares $530.71 million -0.9%8.1%6.5 $126.06 6/15/20244,250,000 shares $533.89 million -1.9%8.2%6.9 $125.62 5/31/20244,330,000 shares $645.56 million -0.5%8.3%8.9 $149.09 5/15/20244,350,000 shares $765.73 million -1.6%8.4%9.6 $176.03 4/30/20244,420,000 shares $725.76 million -3.7%8.5%8.9 $164.20 Get the Latest News and Ratings for RGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repligen and its competitors with MarketBeat's FREE daily newsletter. 4/15/20244,590,000 shares $763.73 million -3.8%8.9%8.7 $166.39 3/31/20244,770,000 shares $877.30 million No Change9.2%8.8 $183.92 3/15/20244,770,000 shares $905.97 million -2.3%9.2%8.9 $189.93 2/29/20244,880,000 shares $946.67 million -8.8%9.4%8.1 $193.99 2/15/20245,350,000 shares $1.10 billion -7.9%10.3%8.8 $206.03 1/31/20245,810,000 shares $1.10 billion -0.2%11.2%9.8 $189.40 1/15/20245,820,000 shares $1.01 billion -2.7%11.2%8.7 $173.21 12/31/20235,980,000 shares $1.08 billion -2.1%11.5%8.7 $179.80 12/15/20236,110,000 shares $1.11 billion +1.8%11.8%9.1 $181.22 11/30/20236,000,000 shares $943.50 million +0.2%11.6%9.1 $157.25 11/15/20235,990,000 shares $934.02 million +0.3%11.5%9.7 $155.93 10/31/20235,970,000 shares $803.32 million -0.2%11.5%9.9 $134.56 10/15/20235,980,000 shares $913.39 million +2.2%11.5%11.5 $152.74 9/30/20235,850,000 shares $930.21 million +6.2%11.3%11.6 $159.01 9/15/20235,510,000 shares $911.91 million +1.3%10.6%10 $165.50 8/31/20235,440,000 shares $946.07 million +0.7%10.5%9.5 $173.91 8/15/20235,400,000 shares $934.42 million -1.8%10.4%8.9 $173.04 7/31/20235,500,000 shares $943.58 million +2.0%10.6%9.1 $171.56 7/15/20235,390,000 shares $811.14 million +0.9%10.4%8.4 $150.49 6/30/20235,340,000 shares $755.40 million -8.6%10.3%9 $141.46 6/15/20235,840,000 shares $940.59 million +5.0%11.3%10.5 $161.06 5/31/20235,560,000 shares $933.64 million +4.9%10.7%10.2 $167.92 5/15/20235,300,000 shares $816.36 million -1.1%10.2%9.1 $154.03 4/30/20235,360,000 shares $812.74 million +10.1%10.4%9.2 $151.63 4/15/20234,870,000 shares $847.53 million +9.2%9.4%8.7 $174.03 3/31/20234,460,000 shares $750.89 million +7.7%8.6%8.2 $168.36 3/15/20234,140,000 shares $706.62 million No Change8.0%7.5 $170.68 2/28/20234,140,000 shares $721.89 million +9.2%8.0%7.7 $174.37 2/15/20233,790,000 shares $742.84 million -6.4%7.3%6.5 $196.00 1/31/20234,050,000 shares $750.47 million -0.5%7.9%7.3 $185.30 1/15/20234,070,000 shares $724.70 million +11.2%7.9%6.9 $178.06 12/30/20223,660,000 shares $619.67 million +2.0%7.1%5.7 $169.31 12/15/20223,590,000 shares $604.02 million +11.5%7.0%5.7 $168.25 11/30/20223,220,000 shares $575.86 million -0.9%6.2%5 $178.84Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… 11/15/20223,250,000 shares $685.23 million +4.2%6.3%5.7 $210.84 10/31/20223,120,000 shares $569.37 million +5.1%6.0%5.7 $182.49 10/15/20222,970,000 shares $574.81 million +11.7%5.8%5.2 $193.54 9/30/20222,660,000 shares $497.71 million +0.8%5.2%4.9 $187.11 9/15/20222,640,000 shares $613.06 million +1.2%5.1%5.1 $232.22 8/31/20222,610,000 shares $572.56 million -7.8%5.1%4.9 $219.37 8/15/20222,830,000 shares $723.72 million -12.4%5.5%5.3 $255.73 7/31/20223,230,000 shares $689.15 million +2.5%6.3%6.2 $213.36 7/15/20223,150,000 shares $525.36 million +10.5%6.1%5.9 $166.78 6/30/20222,850,000 shares $462.84 million +10.0%5.5%5.4 $162.40 6/15/20222,590,000 shares $383.35 million -1.2%6.6%4.8 $148.01 5/31/20222,620,000 shares $430.91 million +2.8%5.1%5.2 $164.47 5/15/20222,550,000 shares $383.52 million -8.3%5.0%5.1 $150.40 4/30/20222,780,000 shares $437.13 million +21.4%5.4%5.4 $157.24 4/15/20222,290,000 shares $361.06 million +3.6%4.5%5 $157.67 3/31/20222,210,000 shares $415.68 million -10.2%4.3%4.9 $188.09 3/15/20222,460,000 shares $417.76 million +5.1%4.8%5.5 $169.82 2/28/20222,340,000 shares $460.28 million +9.9%4.6%5.3 $196.70 2/15/20222,130,000 shares $398.42 million +1.9%4.2%4.8 $187.05 1/31/20222,090,000 shares $414.53 million +29.8%4.1%5 $198.34 1/15/20221,610,000 shares $311.15 million +6.6%3.1%3.7 $193.26 12/31/20211,510,000 shares $399.91 million -9.6%2.9%3.9 $264.84 12/15/20211,670,000 shares $437.26 million -5.1%3.3%4.3 $261.83 11/30/20211,760,000 shares $504.24 million +6.7%3.4%4.2 $286.50 11/15/20211,650,000 shares $431.39 million +3.8%3.2%4.2 $261.45 10/29/20211,590,000 shares $461.90 million -1.9%3.1%4.3 $290.50 10/15/20211,620,000 shares $432.41 million -3.6%3.2%4.4 $266.92 9/30/20211,680,000 shares $485.50 million +5.0%3.3%4.5 $288.99 9/15/20211,600,000 shares $474.24 million +1.9%3.1%4.7 $296.40 8/31/20211,570,000 shares $444.28 million -4.3%3.1%4.8 $282.98 8/13/20211,640,000 shares $423.05 million -4.7%3.2%4.6 $257.96 7/30/20211,720,000 shares $422.60 million +8.2%3.4%4.2 $245.70 7/15/20211,590,000 shares $313.40 million -6.5%3.1%4 $197.11 6/30/20211,700,000 shares $339.35 million -1.2%3.3%4.5 $199.62 6/15/20211,720,000 shares $326.18 million -1.2%3.4%4.2 $189.64 5/28/20211,740,000 shares $317.74 million +5.5%3.4%4.2 $182.61 5/14/20211,650,000 shares $279.92 million +5.8%3.2%3.9 $169.65 4/30/20211,560,000 shares $332.50 million -3.7%3.1%4 $213.14 4/15/20211,620,000 shares $332.57 million +4.5%3.2%4.2 $205.29 3/31/20211,550,000 shares $293.28 million +10.7%3.1%3.8 $189.21 3/15/20211,400,000 shares $272.58 million +3.7%2.8%3.5 $194.70 2/26/20211,350,000 shares $279.54 million -4.9%2.7%3.4 $207.07 2/12/20211,420,000 shares $317.21 million +8.4%2.8%3.6 $223.39 1/29/20211,310,000 shares $256.41 million +7.4%2.6%3 $195.73 1/15/20211,220,000 shares $258.95 million -9.0%2.4%2.8 $212.25 12/31/20201,340,000 shares $253.45 million -2.9%2.7%3.2 $189.14 12/15/20201,380,000 shares $254.04 million -10.4%2.8%3.2 $184.09 11/30/20201,540,000 shares $287.96 million -6.1%3.1%3.7 $186.99 11/15/20201,640,000 shares $337.18 million +12.3%3.4%4.1 $205.60 10/30/20201,460,000 shares $251.44 million -0.7%3.0%4 $172.22Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… 10/15/20201,470,000 shares $249.66 million +9.7%3.0%3.8 $169.84 9/30/20201,340,000 shares $197.70 million -6.3%2.8%3.3 $147.54 9/15/20201,430,000 shares $214.89 million No Change3.0%2.6 $150.27 8/31/20201,430,000 shares $221.52 million +6.7%3.0%2.4 $154.91 8/14/20201,340,000 shares $192.81 million -23.4%2.8%2.1 $143.89 7/31/20201,750,000 shares $264.09 million +2.3%3.6%2.6 $150.91 7/15/20201,710,000 shares $213.48 million +8.9%3.5%2.6 $124.84 6/30/20201,570,000 shares $194.07 million -11.8%3.3%2.4 $123.61 6/15/20201,780,000 shares $202.83 million -8.7%3.7%3.2 $113.95 5/29/20201,950,000 shares $255.39 million -7.1%4.0%3.3 $130.97 5/15/20202,100,000 shares $295.01 million -16.7%4.4%3.5 $140.48 4/30/20202,520,000 shares $294.18 million -15.7%5.3%4.3 $116.74 4/15/20202,990,000 shares $306.98 million +9.9%6.3%5.4 $102.67 3/31/20202,720,000 shares $316.69 million +3.1%5.8%5.1 $116.43 3/13/20202,638,100 shares $261.04 million +28.7%5.6%4.1 $98.95 2/28/20202,050,000 shares $182.25 million -1.9%4.3%4.7 $88.90 2/14/20202,090,000 shares $200.35 million -11.8%4.4%5.3 $95.86 1/31/20202,370,000 shares $201.83 million -3.7%5.0%6.4 $85.16 1/15/20202,460,000 shares $258.72 million +1.7%5.2%6.2 $105.17 12/31/20192,420,000 shares $239.85 million -29.5%5.1%6.1 $99.11 RGEN Short Interest - Frequently Asked Questions What is Repligen's current short interest? Short interest is the volume of Repligen shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 4,230,000 shares of RGEN short. 8.14% of Repligen's shares are currently sold short. Learn More on Repligen's current short interest. What is a good short interest ratio for Repligen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGEN shares currently have a short interest ratio of 6.0. Learn More on Repligen's short interest ratio. Which institutional investors are shorting Repligen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Repligen: Concourse Financial Group Securities Inc., Walleye Trading LLC, Jane Street Group LLC, Twin Tree Management LP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Repligen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.14% of Repligen's floating shares are currently sold short. Is Repligen's short interest increasing or decreasing? Repligen saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 4,230,000 shares, an increase of 0.5% from the previous total of 4,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repligen's float size? Repligen currently has issued a total of 55,880,000 shares. Some of Repligen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repligen currently has a public float of 51,960,000 shares. How does Repligen's short interest compare to its competitors? 8.14% of Repligen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Repligen: Qiagen (1.35%), CRISPR Therapeutics AG (18.98%), Denali Therapeutics Inc. (6.05%), Bio-Techne Co. (2.39%), Adaptive Biotechnologies Co. (8.08%), Alnylam Pharmaceuticals, Inc. (3.55%), BioMarin Pharmaceutical Inc. (3.93%), United Therapeutics Co. (9.57%), Incyte Co. (5.70%), Neurocrine Biosciences, Inc. (2.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Repligen stock? Short selling RGEN is an investing strategy that aims to generate trading profit from Repligen as its price is falling. RGEN shares are trading up $8.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repligen? A short squeeze for Repligen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGEN, which in turn drives the price of the stock up even further. How often is Repligen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGEN, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Qiagen Short Interest CRISPR Therapeutics Short Interest Denali Therapeutics Short Interest Bio-Techne Short Interest Adaptive Biotechnologies Short Interest Alnylam Pharmaceuticals Short Interest BioMarin Pharmaceutical Short Interest United Therapeutics Short Interest Incyte Short Interest Neurocrine Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGEN) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.